about
Determinants of Staphylococcus aureus nasal carriageAntimicrobial polypeptides in host defense of the respiratory tractExoproteome of Staphylococcus aureus reveals putative determinants of nasal carriageSuppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epitheliumThe lactoperoxidase system links anion transport to host defense in cystic fibrosisExpression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infectionAntimicrobial peptide defensin: identification of novel isoforms and the characterization of their physiological roles and their significance in the pathogenesis of diseasesDefensins as anti-inflammatory compounds and mucosal adjuvantsGenome sequencing and analysis reveals possible determinants of Staphylococcus aureus nasal carriageRegulatory adaptation of Staphylococcus aureus during nasal colonization of humans.A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Persistent Staphylococcus aureus colonization is not a strongly heritable trait in Amish familiesPeptide-based Antifungal Therapies against Emerging Infections.Structure of the Neisseria Adhesin Complex Protein (ACP) and its role as a novel lysozyme inhibitor.Hemoglobin promotes Staphylococcus aureus nasal colonization.Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnelAntimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosisDifferent type 1 fimbrial genes and tropisms of commensal and potentially pathogenic Actinomyces spp. with different salivary acidic proline-rich protein and statherin ligand specificities.Characterization of the mouse beta defensin 1, Defb1, mutant mouse model.Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozymePathogenesis of cystic fibrosis airways diseaseMucus clearance as a primary innate defense mechanism for mammalian airways.Longitudinal genetic analyses of Staphylococcus aureus nasal carriage dynamics in a diverse population.pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37Cervical mucus properties stratify risk for preterm birthDeterminants of acquisition and carriage of Staphylococcus aureus in infancyChemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.Implications of the innate immune response to adenovirus and adenoviral vectors.Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways.Characterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonizationEvidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease.A novel siderophore system is essential for the growth of Pseudomonas aeruginosa in airway mucusClinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammationCharacterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells.C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells.Airway acidification initiates host defense abnormalities in cystic fibrosis mice.Proteomic analysis of egg white heparin-binding proteins: towards the identification of natural antibacterial moleculesRespiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriage.
P2860
Q24548849-43C163F0-BBF5-468A-88CB-B22F03A90C19Q24551612-5B7199B0-6E24-444F-9046-435F75C389BBQ24628406-45819E5A-A5DC-4101-97F3-1A6700FB0856Q24655374-C923624F-A54C-4E31-9BAA-E8B76052E5C6Q24683917-BD51238A-5F9D-4D81-9B4C-A9786F605B1BQ24804437-3C684E97-6CCD-45A9-96C0-45276E553A42Q26865308-E5AC99E4-649A-49D8-883F-5E8D1AD81396Q28748926-CD615805-E3B7-474E-BB1B-2B94D48811C2Q33371112-AF76CCB8-2188-4FC3-AA13-2180D009ABC9Q33553375-5DA02745-03A1-4DFB-AA0D-23A7CF152D7EQ33557688-54288A96-D104-4C99-BE98-9757A844C309Q33753950-83F7FE6A-972C-4F6F-884A-B2EB8BBC1E35Q33840963-E54B5C7D-73EE-4E0D-A6BB-BEBEEB47E97BQ33862289-34F670F3-9493-4489-86B4-381CFB72E24BQ33898758-BA475745-4910-49E1-B5CA-DF6073046994Q33959180-126F56D2-3F0A-4473-8A37-F1A7B3E99EDDQ33961106-EA0E75F7-3D51-4161-829E-D375C1ED521BQ34007042-08B1F5AF-CFC8-4548-AAD6-C55004ECAC18Q34009541-DD550FD3-B943-4A13-BEFB-FBD5DC304802Q34124317-03E0B984-6A3A-40D0-909B-AC55E7DCA136Q34130420-D777D42A-8E7B-42AC-A4ED-49FD366509CFQ34286627-DD6C927D-2AD5-47D8-B22A-33F8E7A09E71Q34551378-3A6FEAEB-AE4A-4067-9769-5A9C8EFADDB9Q34725569-4A2DFA3D-DCA5-4B68-97A3-93340603D84CQ34832018-A43E15CE-86E3-4818-B921-83AD4459D98DQ34924455-131D4E6F-26FF-4578-9D06-B73969D65BDAQ34950678-7825E257-B681-4719-834E-7CB1CD73FCF1Q35001584-EC871863-699A-41DE-87AF-568F681077B4Q35085363-4C91E25E-AD85-4F11-B8B9-89E700B4EDD3Q35191858-392EDFE0-FCC2-4415-97FA-A1D20EDA7549Q35363804-8DF0DE39-B2F6-4E57-936A-F34B608721F6Q36109179-184803A4-9527-4EF8-961E-5CBD8B9B6426Q36134138-EF2D2052-241F-4F6F-B467-460366405468Q36244018-AC03BC43-08DF-432D-AB17-E5AF2A5D935FQ36383135-10DDF85F-1A02-4E4E-9316-4FC99C695756Q36575431-D3D48F7B-E846-4C05-9EEC-8BB143AA52D3Q36857687-DD13C44B-9157-417D-ABD2-8B81A735D94DQ36997303-EAB0A413-7CD2-4FF4-8EDD-EC1B63F6757DQ37098637-D2242163-D75F-48AC-8FED-FF434799605CQ37150121-7246981A-6968-4417-9B1A-C933233E3600
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Innate antimicrobial activity of nasal secretions.
@ast
Innate antimicrobial activity of nasal secretions.
@en
type
label
Innate antimicrobial activity of nasal secretions.
@ast
Innate antimicrobial activity of nasal secretions.
@en
prefLabel
Innate antimicrobial activity of nasal secretions.
@ast
Innate antimicrobial activity of nasal secretions.
@en
P2093
P2860
P1476
Innate antimicrobial activity of nasal secretions
@en
P2093
P2860
P304
P407
P50
P577
1999-07-01T00:00:00Z